Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian markets take a breather
Wed, 5 Oct 09:30 am

Asian stock markets have opened the day on a mixed note. Stock markets in South Korea (down 1.6%), Japan (down 0.8%) and Taiwan (down 0.5%) are trading in the red, while markets in Indonesia (up 0.9%) and Malaysia (up 0.6%) are trading firm. The Indian stock markets have opened the day on a firm note. Stocks in the capital goods, Information Technology (IT) and metal space are leading the gains.

The BSE-Sensex is trading higher by around 133 points (0.8%), the NSE-Nifty is up by around 38 points (0.8%). Mid cap and small cap stocks have opened on a positive note with BSE Mid Cap and BSE Small Cap indices up by 0.9% and 0.5% respectively. The rupee is trading at 49.11 to the US dollar.

Oil & Gas Stocks have opened the day on a mixed note with Oil India and Bharat Petroleum Corporation Ltd (BPCL) trading in the red, while Essar Oil and Petronet LNG are trading firm. The newly appointed Chairman of Oil and Natural Gas Corporation (ONGC) has, said that the company will focus on exploration activities. By 2014, ONGC plans to raise the output of crude oil to 28 m tonnes per year. By 2017, it also plans to raise the gas output to 100 m standard cubic metres per day. To achieve this target the company will bring in foreign partners. ONGC has always been criticised for its declining output or not meeting projections. The current crude oil output for 2010-11 was 24.4 m tonnes. The Chairman also said that the existing fields are old but are still the cash-cows for the company. The increase in output will require ONGC to invest Rs 260 bn.

Pharma Stocks have opened the day on a firm note with Opto Circuits, Orchid Chemicals and Cadila Healthcare trading in the green. India's largest generic pharma company, Ranbaxy Laboratories, said that it has entered into a partnership with its parent company, Daiichi Sankyo to distribute the Japanese firm's products in Italy. The statement said that Ranbaxy Italia SpA and Daiichi Sankyo, Italia SpA announced a partnership to leverage Ranbaxy's distribution strengths and extensive relationships with pharmacists across Italy, for the distribution of Daiichi Sankyo products. Initially, Ranbaxy will exclusively distribute two of the parent's established brands named Congescor and Lopresor. The selling will be done to all pharmacies in Italy. Both these drugs are used in Italy for the treatment of congestive heart failure and hypertension.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian markets take a breather". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.